Literature DB >> 3595812

Familial malignant blood disease in the country of Jämtland, Sweden.

M Eriksson, I Bergström.   

Abstract

In a material of 942 patients with malignant hematological disease, encompassing all diagnosed cases in the country of Jämtland in Sweden during a 22-yr period, 36 families with multiple cases of such disease were found. Approximately 5% of the patients have at least one close relative who also suffers from a malignant hematological disease. An especially strong familial occurrence was found in the group of chronic lymphoproliferative diseases and it is concluded that this tendency comprises all diseases in the group, i.e. chronic lymphocytic leukemia, multiple myeloma and malignant lymphoma. In some families several cases of acute leukemia were present, and suggestions concerning immunological disturbances are made. In the group of chronic myeloproliferative diseases familial factors do not seem to play an important part, with the possible exception of polycythemia vera. Both heredity and common environmental agents must be considered as possible etiologic factors.

Entities:  

Mesh:

Year:  1987        PMID: 3595812     DOI: 10.1111/j.1600-0609.1987.tb01170.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

1.  Occupational and other environmental factors and multiple myeloma: a population based case-control study.

Authors:  M Eriksson; M Karlsson
Journal:  Br J Ind Med       Date:  1992-02

2.  Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

Authors:  M Eriksson; B Hållberg
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

3.  Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.

Authors:  Silvana Capalbo; Vincenzo Callea; Caterina Musolino; Patrizia Guglielmo; Giovanni D'Arena; Alberto Fragasso; Cosima Battista; Rosario Giustolisi; Maura Brugiatelli; Vincenzo Liso
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.